3-氯-4-甲氧基苯井 | 24630-85-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氯-4-甲氧基苯井
• 中文别名: (3-氯-4-甲氧基苯基)-肼
• 英文名称: 3-Chloro-4-methoxyphenylhydrazine
• 英文别名: 1-(3-chloro-4-methoxyphenyl)hydrazine；(3-chloro-4-methoxyphenyl)hydrazine；3-Chloro-4-methoxy-phenylhydrazin
• CAS: 24630-85-1
• 化学式: C₇H₉ClN₂O
• mdl: MFCD02663088
• 分子量: 172.614
• InChiKey: GJUNJVKCSTWNJG-UHFFFAOYSA-N

物化性质

• 熔点：
  68℃
• 沸点：
  296℃
• 密度：
  1.307
• 闪点：
  133℃

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  47.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2928000090

反应信息

• 作为反应物：
  描述：

  3-氯-4-甲氧基苯井 在 溶剂黄146 、 锌 作用下， 以 乙醇 为溶剂， 反应 16.0h， 生成
  参考文献：
  名称：

  Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure–activity relationship

  摘要：

  Installation of sites for metabolism in the lead compound PHA-767408 was the key focus of the IKK-2 inhaled program. This paper reports our efforts to identify a novel series of aminopyridinecarboxamide-based IKK-2 inhibitors, which display low nanomolar potency against IKK-2 with long duration of action (DOA), and metabolically labile to phase I and/or phase II metabolizing enzymes with potential capability for multiple routes of clearance. Several compounds have demonstrated their potential usefulness in the treatment of asthma and chronic obstructive pulmonary disease (COPD). (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2010.12.027
• 作为产物：
  描述：

  3-氯-4-甲氧基苯胺 在 盐酸 、 sodium nitrite 、 tin(ll) chloride 、 水 、 potassium carbonate 作用下， 以 水 为溶剂， 反应 2.0h， 以30.77%的产率得到3-氯-4-甲氧基苯井
  参考文献：
  名称：

  Aminopyridinecarboxamide-based inhaled IKK-2 inhibitors for asthma and COPD: Structure–activity relationship

  摘要：

  Installation of sites for metabolism in the lead compound PHA-767408 was the key focus of the IKK-2 inhaled program. This paper reports our efforts to identify a novel series of aminopyridinecarboxamide-based IKK-2 inhibitors, which display low nanomolar potency against IKK-2 with long duration of action (DOA), and metabolically labile to phase I and/or phase II metabolizing enzymes with potential capability for multiple routes of clearance. Several compounds have demonstrated their potential usefulness in the treatment of asthma and chronic obstructive pulmonary disease (COPD). (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2010.12.027

文献信息

• Pyridazino quinoline compounds
  申请人：Zeneca Limited

  公开号：US06214826B1

  公开（公告）日：2001-04-10

  The invention relates to pyridazinoquinoline compounds of the formulas B and B′ wherein Ring A is selected from an ortho fused aromatic or heteroaromatic five- or six-membered ring and R1, R3 and R4 are substituents selected from halo, OH, OCF3, NO2, CN, NR′R″, SO2NR′R″, SOmR′alkyl, and a variety of alkyl, aryl, heterocyclic and heteroaryl groups, to pharmaceutical compositions containing them and to methods utilizing them for the treatment of neurological disorders.

  本发明涉及公式B和B′的吡啶氮杂喹啉化合物 其中，环A为选自邻位稠合的芳香族或杂芳香的五元或六元环，R1、R3和R4为取代基，选自卤素、OH、OCF3、NO2、CN、NR′R″、SO2NR′R″、SOmR′烷基以及各种烷基、芳基、杂环和杂芳基，还涉及含有这些化合物的药物组合物以及使用它们治疗神经系统疾病的方法。
• Pyridazion quinoline compounds
  申请人：Zeneca Limited

  公开号：US05744471A1

  公开（公告）日：1998-04-28

  The present invention relates to compounds, pharmaceutical compositions and methods of using compounds of formula (I) in the treatment and/or prevention of certain diseases or conditions. In formula (I), A is chosen from ortho substituted aryl or heteroaryl species, X is chosen from --OH, --SH, NHR and R.sup.1 or R.sup.2 is chosen from --(CH.sub.2).sub.n L wherein L may be selected from a variety of substituents including aryl, heteroaryl and heterocyclic groups. The compounds are useful in treating and/or preventing neurological disorders associated with excitatory amino acids. ##STR1##

  本发明涉及化合物、药物组合物和使用化合物（I）的方法，用于治疗和/或预防特定疾病或状况。在式（I）中，A选择自于邻位取代的芳基或杂环芳基，X选择自于—OH，—SH，NHR和R.sup.1或R.sup.2选择自于—(CH.sub.2).sub.n L，其中L可以从各种取代基中选择，包括芳基、杂环芳基和杂环基。这些化合物可用于治疗和/或预防与兴奋性氨基酸相关的神经疾病。
• Synthesis of COX-2 and FAAH inhibitors
  申请人：Bartolini Wilmin

  公开号：US20050234244A1

  公开（公告）日：2005-10-20

  Methods for preparing indoles that are useful COX-2 inhibitors and intermediates useful in such methods are described.

  描述了制备对COX-2抑制剂有用的吲哚和在这些方法中有用的中间体的方法。
• Useful indole compounds
  申请人：Bartolini Wilmin

  公开号：US20070203209A1

  公开（公告）日：2007-08-30

  Indoles having various activities, including indoles that are CRTH2 are described. The compounds are useful for treating asthma, neuropathic pain, allegic rhinitis and other disorders.

  本文描述了具有多种活性的吲哚类化合物，包括CRTH2的吲哚类化合物。这些化合物可用于治疗哮喘、神经病性疼痛、过敏性鼻炎和其他疾病。
• Use of substituted oxadiazoles for combating phytopathogenic fungi
  申请人：BASF SE

  公开号：US10442777B2

  公开（公告）日：2019-10-15

  The present invention relates to the use of novel oxadiazoles of the formula I or an N-oxide and/or their agriculturally useful salts for controlling phytopathogenic fungi, or to a method for combating phytopathogenic harmful fungi, which process comprises treating the fungi or the materials, plants, the soil or seeds to be protected against fungal attack, with an effective amount of at least one compound of formula I or an N-oxide or an agriculturally acceptable salt thereof; and to agrochemical compositions comprising at least one such compound and to agrochemical compositions further comprising seeds.

  本发明涉及式 I 的新型噁二唑或其 N-氧化物和/或其农业上有用的盐在控制植物病原真菌方面的用途，或涉及一种防治植物病原有害真菌的方法，该方法包括用有效量的至少一种式 I 的化合物或其 N-氧化物或其农业上可接受的盐处理真菌或待保护的材料、植物、土壤或种子，使其免受真菌侵袭；以及包含至少一种此类化合物的农用化学品组合物和进一步包含种子的农用化学品组合物。